What Innovacyn does

Innovacyn is a privately held, family-owned pharmaceutical and medical device company founded in 2009 by Bob Burlingame and headquartered in Rialto, California. The company develops, manufactures, and distributes wound care and skin care products based on a proprietary, patent-pending electrochemical treatment process that converts diluted saltwater into a pH-balanced hypochlorous acid solution. This core technology platform underpins three sub-brands: Vetericyn (animal health — covering companion pets, livestock, equine, and veterinary professionals), Puracyn (human health — covering healthcare provider and OTC consumer wound care), and SKV Scientific (industrial wastewater management, sanitation, and disinfection). The company's products are FDA-cleared, non-cytotoxic, non-irritating, antibiotic-free, and preservative-free with stable shelf life, manufactured in an FDA-registered, ISO 13485-certified facility with capacity exceeding 4 million bottles per month.

The business operates a sales-led, multi-channel distribution model reaching both B2B and direct-to-consumer end markets. Animal health products are sold through veterinary clinics, feed stores, livestock operators, and the vetericyn.com e-commerce site; human health products are sold through hospitals, healthcare providers, retailers, and puracynplus.com. Distribution extends through partner networks across North America and international markets, supported by quote-based wholesale pricing. Marketing combines owned e-commerce, industry trade shows, email/newsletter campaigns, traditional advertising (TV, radio, print), referrals from veterinarians and healthcare providers, and B2B partner marketing. The leadership team is dominated by Burlingame-family executives with multi-decade tenure at Burlingame Industries, supplemented by specialty VPs in technical operations, manufacturing, and sales for both animal and human health verticals.

Revenue is generated through one-time product sales across the portfolio, with the company reporting 11-50 employees. No external funding rounds have been disclosed, consistent with the family-owned operating model. Production assets, FDA and ISO certifications, and a 16-year operating history indicate an established manufacturing business that has progressively expanded its addressable market from animal wound care into human wound care and adjacent industrial sanitation applications, though specific revenue figures and growth rates are not publicly disclosed.

Name

Innovacyn

Legal name

INNOVACYN, INC.

Website

https://innovacyn.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Innovacyn is a family-owned pharmaceutical company that manufactures FDA-cleared wound and skin care products for humans and animals using a proprietary electrochemical process that converts diluted saltwater into pH-balanced hypochlorous acid solutions, sold across veterinary, healthcare, retail, and e-commerce channels globally.

Ownership category

akta.pro rank

Product category

Wound Care Products

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414), Soap and Cleaning Compound Manufacturing (32561)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Specialty Cleaning, Polishing And Sanitation Preparations (2842)

akta.pro primary industry

Dermatology & Allergy Drugs (HLAMAEAH)

akta.pro secondary industries

Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Antimicrobials & Anti-infectives (HLAMAEAE)

Keywords

• Wound care products
• Hypochlorous acid solutions
• Animal wound care
• Human wound care
• Veterinary pharmaceuticals

Headquarters

HQ city

Rialto

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure

Revenue model

1. Product Sales - Animal Health: Sale of wound care and skin care products for animals through Vetericyn brand, including Vetericyn Plus, Vetericyn Plus VF (veterinary professionals), FoamCare, Vetericyn Livestock, and Vetericyn Mobility. Distributed through veterinarians, feed stores, distributors, and direct-to-consumer e-commerce.
2. Product Sales - Human Health: Sale of wound care products for humans through Puracyn brand, including Puracyn Plus Professional (for healthcare providers) and Puracyn Plus OTC (over-the-counter). Distributed through healthcare providers, retailers, and direct-to-consumer e-commerce.
3. Industrial/Commercial Products: SKV Scientific products for wastewater management, sanitation, disinfection, and infectious disease control for industrial and commercial applications.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

Innovacyn manufactures and sells FDA-cleared wound and skin care solutions built around a proprietary, patent-pending electrochemical process that converts diluted saltwater into pH-balanced hypochlorous acid. The company sells its products under three brands: Vetericyn (animal health, including pets, livestock, and equine), Puracyn (human health, both professional and OTC), and SKV Scientific (industrial sanitation, disinfection, and wastewater management). Products are distributed through B2B channels (veterinarians, feed stores, distributors, healthcare providers) and direct-to-consumer e-commerce.

Product overview

Innovacyn is a family-owned healthcare company that offers a unified portfolio of wound care products for both human and animal health markets. The core technology is a patent-pending electrochemical treatment process using diluted saltwater to generate pH-balanced hypochlorous acid solutions. The product family includes Vetericyn Plus and related animal health products (Vetericyn Plus VF, FoamCare, Vetericyn Livestock, ALL-IN Dog Supplements, Vetericyn Mobility) under the Vetericyn brand for animal wellness, and Puracyn Plus (Professional and OTC formulations) for human wound care, along with SKV Scientific sub-brand products for sanitation and disinfection applications.

Differentiator

Problem solved

Functional benefit

Brands

• Vetericyn Plus: Wound and skin care products for animal health
• Vetericyn Plus VF
• FoamCare
• Vetericyn Livestock
• Puracyn Plus Professional
• Puracyn Plus OTC
• SKV Scientific
• ALL-IN Dog Supplements
• Vetericyn Mobility

Products and services

• Puracyn Plus Professional

Quantifiable outcome

• Manufacturing capacity: Over 4 million bottles per month
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered minor.

• ILWTI (Institute for Laboratory Animal Welfare)minorOthersInnovacyn supports organizations with shared vision for healing and health worldwide. ILWTI focuses on laboratory animal welfare and Innovacyn donates products to support their mission.
• WoundReachminorOthersInnovacyn actively supports WoundReach, an organization dedicated to wound care education and treatment, reflecting shared values in healthcare improvement.
• Project MedishareminorOthersInnovacyn supports Project Medishare, a nonprofit improving health in Haiti, demonstrating commitment to global healthcare access.
• World VetsminorOthersInnovacyn partners with World Vets to provide veterinary care and products to animals in need globally.
• Blue Angels FoundationminorOthersInnovacyn supports the Blue Angels Foundation, providing assistance to military families and first responders.
• Walleyes for WarriorsminorOthersInnovacyn supports Walleyes for Warriors, an organization providing therapeutic fishing experiences for veterans.
• Alpha K9minorOthersInnovacyn partners with Alpha K9 to support working dog health and wellness programs.
• Petco FoundationminorOthersInnovacyn supports the Petco Foundation in their mission to save pet lives and promote animal welfare.
• Point HopeminorOthersInnovacyn supports Point Hope, an organization focused on humanitarian efforts and animal welfare.
• DEBRA (Dystrophic Epidermolysis Bullosa Research Association)minorOthersInnovacyn supports DEBRA, the organization dedicated to finding a cure for epidermolysis bullosa and providing support to those affected.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Virbac: Virbac is a global animal health pharmaceutical company with strong veterinary dermatology and wound care lines, particularly in companion animals. Most directly comparable to Vetericyn within the veterinary dermatology category.
• ConvaTec: ConvaTec is a major advanced wound care and ostomy player with strong hospital relationships. Overlaps with Innovacyn in chronic and post-surgical wound management but offers a much broader portfolio of devices and dressings.
• Mölnlycke Health Care: Mölnlycke is a global leader in wound care (Mepilex, Mepitel) and infection prevention. Competes with Puracyn Plus Professional in the same hospital and community wound care channels.
• Dechra Pharmaceuticals: Dechra specializes in veterinary pharmaceuticals with strong dermatology, pain management, and wound care franchises. Closely comparable to Vetericyn within veterinary channel positioning and product focus.
• Elanco Animal Health: Elanco is a global animal health company with companion animal and livestock offerings that compete for veterinary clinic shelf space and distribution partnerships alongside Vetericyn.
• Smith+Nephew: Smith+Nephew's Advanced Wound Management division competes directly with Puracyn in hospital and community wound care through dressings, negative pressure, and topical solutions. A global incumbent that Innovacyn must displace in hospital accounts.
• Zoetis: Zoetis is the largest pure-play animal health pharmaceutical company and a natural benchmark for Vetericyn's animal health franchise, even though it does not directly compete in hypochlorous wound care. Useful as a comparable for animal health commercial scale.
• 3M Health Care (Solventum post-spin): 3M/Solventum is a dominant incumbent in advanced wound care dressings and skin health, serving hospitals and consumers. Competes with Puracyn Plus in the same wound management category but with a much broader product portfolio.

Direct peers

• PuriCore: PuriCore develops and commercializes hypochlorous acid and electrochemical solutions for wound care, food safety, and hard-surface disinfection. Its technology base and end-market overlap (human/animal/industrial) closely mirror Innovacyn.
• Anacore (formerly Oculus Innovative Sciences): Anacore is the closest direct competitor, also commercializing hypochlorous acid-based wound and skin care products (Microcyn) for human and animal health using a proprietary electrochemical process. It overlaps directly with both Vetericyn and Puracyn in chemistry, channel, and customer use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovacyn